India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

The first 10 prescription drugs subject to Medicare price negotiations go into effect on Jan. 1. Medicare beneficiaries will see substantially lower costs for those treatments in 2026, according to a ...

When Heather Povinelli was in teacher training while in college, there was a moment she believed her dwarfism would thwart her dream of becoming a teacher — a kindergartner grabbed her on the ...

Mat Myers, in his seventh season as the Bruins’ video coordinator, has always had to adapt. To leverage his size, though not in the conventional hockey sense of dealing out bodychecks or grinding in ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

Last month, the U.S. Senate narrowly rejected a bipartisan resolution recently that would have prevented the Trump administration from launching military strikes in Venezuela without congressional ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...

Popular weight loss drugs like Wegovy and Zepbound will soon cost Americans less under a new deal announced by President Donald Trump on Thursday. Agreements with drugmakers Novo Nordisk and Eli Lilly ...